Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the ...

Thiruvananthapuram: Health minister Veena George announced the launch of the Vishu Kaineettam project, aimed at supporting ...

Conclusion: A single-dose intravenous salbutamol bolus of 15 µg/kg administered over 10 mins in the initial treatment of children with acute severe asthma in the emergency department has the ...

A systematic review and meta-analysis indicates that adding a low dose of a widely available antimalaria drug to ...

"Significant changes were observed in the lives of these children. The treatment age limit ... This initiative cannot be ...

A global biopharma is fighting malaria in endemic countries through partnerships that harness R&D, broaden access to ...

A 1-year-old boy in Ingham County now has the measles, after exposure to a 12-month-old girl who also has the highly ...

"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by chikungunya virus: Saint Herblain, France Wednesday, April 16 ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

The FDA has accepted for review the sBLA for fremanezumab-vfrm for the prevention of episodic migraine in pediatric patients aged 6 to-17 years weighing at least 45 kg.

Dose and frequency should be adjusted based on antithrombin activity, using the Innovance Antithrombin companion diagnostic test. The Food and Drug Administration (FDA) has approved Qfitlia ...